TrademarkDir
EVO TEARS
LIVE

Serial Number

79325079

Owner

URSAPHARM Arzneimittel GmbH

Attorney

Ellen A. Andelman

Filing Date

Aug 2, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EVO TEARS Trademark

Serial Number: 79325079 • Registration: 7057673

EVO TEARS is a trademark filed by URSAPHARM Arzneimittel GmbH on August 2, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

URSAPHARM Arzneimittel GmbH (31 trademarks)

lndustriestraße 35

Entity Type: 16

Trademark Details

Filing Date

August 2, 2021

Registration Date

May 23, 2023

Published for Opposition

October 4, 2022

Goods & Services

Pharmaceutical, medical and veterinary preparations, namely, namely ophthalmologic preparations and eye drops; pharmaceutical preparations for ophthalmological use; pharmaceutical and veterinary preparations for the treatment of ophthalmological conditions, diseases and disorders; contact lens cleaning solutions; solutions for contact lenses; solutions for rinsing contact lenses; disinfectants for contact lenses; contact lens wetting solutions; solutions for neutralizing contact lenses; medicinal creams for the treatment of ophthalmological conditions, diseases and disorders, pharmaceutical creams for the treatment of ophthalmological conditions, diseases and disorders; ophthalmological ointments for the treatment of ophthalmological conditions, diseases and disorders; eye drops; ophthalmologic preparations

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 2, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 17, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 24, 2023 FICS
FINAL DISPOSITION PROCESSED
Aug 24, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 23, 2023 FICR
TEAS SECTION 7 REQUEST RECEIVED
Jun 13, 2023 ES7R
POST PUBLICATION AMENDMENT – NOT ENTERED
May 23, 2023 CHPN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 23, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 23, 2023 R.PR
ASSIGNED TO PETITION STAFF
May 16, 2023 APET
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 1, 2023 OPNX
TEAS POST PUBLICATION AMENDMENT RECEIVED
Apr 25, 2023 EPPA
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Apr 13, 2023 ETOP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 12, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 12, 2023 OPNR
EXTENSION OF TIME TO OPPOSE RECEIVED
Nov 3, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 4, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Oct 3, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 14, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 14, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 14, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2022 TROA
REFUSAL PROCESSED BY IB
Mar 22, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 25, 2022 RFCS
REFUSAL PROCESSED BY MPU
Feb 25, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 31, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jan 30, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 19, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 16, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 12, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 11, 2021 REPR

Related Trademarks

More from this Owner

HYLO RELIEF

HYLO RELIEF

HYLO RELIEF

HYLO RELIEF

HYLO RELIEF

HYLO RELIEF

HYLO OPTIX

HYLO OPTIX

HYLO OPTIX

HYLO OPTIX

HYLO OPTIX

HYLO OPTIX